5007102022-04-012022-06-305007102022-06-305007102022-04-012022-06-30in-bse-fin:OtherExpenses1Member5007102022-04-012022-06-30in-bse-fin:ReportableSegments1Member5007102022-04-012022-06-30in-bse-fin:ReportableSegments1Member5007102022-04-012022-06-30in-bse-fin:ReportableSegments1Member5007102022-06-30in-bse-fin:ReportableSegments1Member5007102022-04-012022-06-30in-bse-fin:ReportableSegments1Member5007102022-06-30in-bse-fin:ReportableSegments1Member5007102022-04-012022-06-30ItemsThatWillNotBeReclassifiedToProfitAndLoss1iso4217:INRiso4217:INRxbrli:shares500710AKZOINDIANOTLISTEDINE133A01011Akzo Nobel India LimitedEquity2022-04-012023-03-312022-08-052022-07-04INRMillionsFirst quarterGeographical2022-08-0511:00:002022-08-0512:55:00Not applicable2022-04-012022-06-30UnauditedConsolidated93769970004065000094176470005331291000592349000-2017660007598440002375600019272500016849140008383113000103453400001034534000280339000-144030002659360000768598000000076859800033793000802391000004554000001016.87616.8760016.87616.8761. The Statement of Consolidated Unaudited Financial Results has been reviewed by the Audit Committee and approved by the Board of Directors in their meeting held on 5 August 2022. The figures for the quarter ended 30 June 2022 have been subjected to limited review by the statutory auditors. <BR> <BR> 2. The figures for the quarter ended 31 March 2022 have not been subjected to review/audit by the statutory auditors. These are balancing figures between Consolidated Audited Financial Statements for the financial year ended 31 March 2022 and year to date Consolidated Unaudited figures of nine months ended 31 December 2021. <BR> <BR> 3. The Consolidated Unaudited Financial Results include the results of the following entities namely, Akzo Nobel India Limited (Parent) and ICI India Research and Technology Centre (Subsidiary). <BR> <BR> 4. In the quarter and year ended 31 March 2022, the Group had reversed an excess provision amounting to INR 20 Mn which was created in earlier years in relation to its erstwhile divested business. This has been disclosed as an exceptional item. <BR> <BR> 5. Current tax expense for the quarter ended 30 June 2021 and year ended 31 March 2022 is net of INR 169 Mn and INR 162 Mn respectively on account of reversal of tax provision pursuant to conclusion of assessments of certain earlier years. <BR> <BR> 6. The Group operates in single segment viz. Coatings. Therefore, separate segment disclosures under the provisions of Ind AS 108 have not been given in respect of Consolidated Unaudited Financial Results for the quarter ended 30 June 2022. <BR> <BR> 7. In preparation of Consolidated Unaudited Financial Results for the quarter ended 30 June 2022, the Group has taken into account the possible impact of COVID-19 and the related internal and external factors known to the management upto the date of approval of these Consolidated Unaudited Financial Results to assess the carrying amount of its assets and liabilities. Accordingly, no material impact is anticipated in these Consolidated Unaudited Financial Results. <BR> <BR> 8. Previous period figures have been regrouped / reclassified, wherever necessary, to make them comparable to the current period figures. <BR> <BR> <BR> <BR> Other expenses1684914000Coatings937699700093769970009376997000Coatings105829000010582900001058290000Coatings259054380002590543800025905438000Coatings259054380002590543800025905438000Gain/(Loss) of defined benefit plans4515800045158000113650000